As you know, throughout 2018 there have been supply constraints of the EpiPen® and EpiPen® Jr auto-injectors in Canada, which meant that at times you may have been unable to fill your prescriptions.
Pfizer Canada has advised that the overall supply of EpiPen (0.3 mg) and EpiPen Jr (0.15 mg) are now fully available in pharmacies across Canada and that everyone should be able to obtain their complete EpiPen prescription. Please read Pfizer’s update, along with Health Canada’s posting for EpiPen and EpiPen Jr on the Drug Shortages Canada website noting that the supply constraints have been resolved.
While this is great news, we remain focused on advocating for always having a minimum of two epinephrine auto-injector suppliers in Canada. You have our commitment that we will continue our ongoing collaborations with the Government of Canada, the Provinces, pharmaceutical companies, and other key stakeholders to ensure you have greater access to this life-saving medication in the long-term.
Please note the temporary supply of AUVI-Q® auto-injectors that was made available during the supply shortage is still available. For more information on the supply of AUVI-Q, please read our FAQs developed in collaboration with Health Canada and kaléo.
For further information or questions regarding the supply of EpiPen, please contact Pfizer Canada directly at 1-877-EPIPEN1 (1-877-374-7361).